Best drug therapy for paranoid schizophrenia in a thinly built 21-years old young male would be-
**Question:** Best drug therapy for paranoid schizophrenia in a thinly built 21-years old young male would be-
A. Haloperidol
B. Risperidone
C. Quetiapine
D. Olanzapine
**Core Concept:**
Paranoid schizophrenia is a severe mental disorder characterized by distorted thoughts, perceptions, and behavior. Treatment options for schizophrenia often involve antipsychotic drugs that target dopamine D2 receptors in the brain, thereby reducing psychotic symptoms. In this context, antipsychotic drugs are classified as either conventional (first-generation) or atypical (second-generation).
**Why the Correct Answer is Right:**
For a thinly built, young male patient, the choice of antipsychotic drug should consider factors such as weight gain, sedation, extrapyramidal side effects (EPS), and prolactin elevation, which are more common with conventional antipsychotics. Considering these factors, atypical antipsychotics are preferred due to their reduced risk of these adverse effects.
**Why Each Wrong Option is Incorrect:**
A. Haloperidol (conventional antipsychotic) is associated with higher risks of weight gain, EPS, and prolactin elevation, making it less suitable for the described patient.
B. Risperidone (conventional antipsychotic) also has higher risks of weight gain, EPS, and prolactin elevation, similar to Haloperidol, making it an unsuitable option as well.
C. Quetiapine (atypical antipsychotic) can cause weight gain and mild sedation, but it is less likely to cause EPS and prolactin elevation, making it a reasonable choice for the described patient.
D. Olanzapine (atypical antipsychotic) has a higher risk of weight gain, sedation, and prolactin elevation, making it less suitable compared to B and C.
**Clinical Pearl:**
When selecting antipsychotic medications, considering the patient's age, body build, and potential adverse effects is crucial. Atypical antipsychotics, such as Quetiapine, are generally preferred due to their lower risk of extrapyramidal side effects and prolactin elevation. However, individual patient factors like age and body build should be taken into account when making the final decision.